[Studies on anti-inflammatory agents. 18. Effect of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridine (Y-3642) on the release of histamine in vitro and in vivo].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001593:Benzyl Compounds / Q000494:pharmacology; D003864:Depression, Chemical; D003911:Dextrans / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D005439:Flufenamic Acid / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects*; D066298:In Vitro Techniques; D008407:Mast Cells / Q000187:drug effects; D010653:Phenylbutazone / Q000494:pharmacology; D011113:Polymyxins / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D013876:Thiophenes / Q000494:pharmacology; D013925:Thromboplastin / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D001593:Benzyl Compounds; D003911:Dextrans; D011113:Polymyxins; D011725:Pyridines; D013876:Thiophenes; D005439:Flufenamic Acid; D004155:Diphenhydramine; D013925:Thromboplastin; D010653:Phenylbutazone; D001241:Aspirin